Immune System Disorders research hub

A Phase 3, Multicenter, Open Label, Basket, Long-term Extension Study of Icotrokinra in Pediatric Clinical Study Participants

This study looks at a new medicine called icotrokinra for children and young people with immune system conditions. It is an extension study, meaning it offers ongoing treatment to young patients who finished an earlier trial, helping doctors learn about the medicine's long-term safety, effects, and benefits.